Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lenvatinib Mesilate Capsules

Approval Number

国药准字H20223157

Company江西山香药业有限公司

Registration Date

March 22, 2022

Drug Information

Generic Name

甲磺酸仑伐替尼胶囊

Dosage Form

胶囊剂

Strength

4mg（按C21H19ClN4O4计）

Drug Type

化学药品

Registration Date

March 22, 2022

Company Information

Applicant Company

Company Name江西山香药业有限公司

Company Address

江西省赣州经济技术开发区凤凰路116号

Manufacturing Company

Company Name江西山香药业有限公司

Company Address

江西省赣州经济技术开发区凤凰路116号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲磺酸仑伐替尼胶囊 - NMPA 批准文号 | MedPath